Skip to main content
Erschienen in: Journal of Gastroenterology 12/2016

30.03.2016 | Original Article—Alimentary Tract

Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center

verfasst von: Jeung Hui Pyo, Sung Noh Hong, Byung-Hoon Min, Jun Haeng Lee, Dong Kyung Chang, Poong-Lyul Rhee, Jae Jun Kim, Sun Kyu Choi, Sin-Ho Jung, Hee Jung Son, Young-Ho Kim

Erschienen in: Journal of Gastroenterology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Rectal neuroendocrine tumor (NET) is the most common NET in Asia. The risk factors associated with rectal NETs are unclear because of the overall low incidence rate of these tumors and the associated difficulty in conducting large epidemiological studies on rare cases. The aim of this study was to exploit the benefits of big data analytics to assess the risk factors associated with rectal NET.

Methods

A retrospective case–control study was conducted, including 102 patients with histologically confirmed rectal NETs and 52,583 healthy controls who underwent screening colonoscopy at the Center for Health Promotion of the Samsung Medical Center in Korea between January 2002 and December 2012. Information on different risk factors was collected and logistic regression analysis applied to identify predictive factors.

Results

Four factors were significantly associated with rectal NET: higher levels of cholesterol [odds ratio (OR) = 1.007, 95 % confidence interval (CI), 1.001–1.013, p = 0.016] and ferritin (OR = 1.502, 95 % CI, 1.167–1.935, p = 0.002), presence of metabolic syndrome (OR = 1.768, 95 % CI, 1.071–2.918, p = 0.026), and family history of cancer among first-degree relatives (OR = 1.664, 95 % CI, 1.019–2.718, p = 0.042).

Conclusion

The findings of our study demonstrate the benefits of using big data analytics for research and clinical risk factor studies. Specifically, in this study, this analytical method was applied to identify higher levels of serum cholesterol and ferritin, metabolic syndrome, and family history of cancer as factors that may explain the increasing incidence and prevalence of rectal NET.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Karzinoide SO. Tumoren des Dunndarms. Frankf Z Pathol. 1907;1:426–32. Karzinoide SO. Tumoren des Dunndarms. Frankf Z Pathol. 1907;1:426–32.
3.
Zurück zum Zitat Jernman J, Valimaki MJ, Louhimo J, Haglund C, Arola J. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Neuroendocrinology. 2012;95:317–24.CrossRefPubMed Jernman J, Valimaki MJ, Louhimo J, Haglund C, Arola J. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Neuroendocrinology. 2012;95:317–24.CrossRefPubMed
4.
Zurück zum Zitat Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Geneva: World Health Organization, 2010. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Geneva: World Health Organization, 2010.
5.
6.
Zurück zum Zitat Naunheim KS, Zeitels J, Kaplan EL, et al. Rectal carcinoid tumors—treatment and prognosis. Surgery. 1983;94:670–6. Naunheim KS, Zeitels J, Kaplan EL, et al. Rectal carcinoid tumors—treatment and prognosis. Surgery. 1983;94:670–6.
7.
Zurück zum Zitat Scherubl H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy. 2009;41:162–5.CrossRefPubMed Scherubl H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy. 2009;41:162–5.CrossRefPubMed
8.
Zurück zum Zitat Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefPubMed Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.CrossRefPubMed
9.
Zurück zum Zitat Cho MY, Kim JM, Sohn JH, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000–2009: multicenter study. Cancer Res Treat. 2012;44:157–65. Cho MY, Kim JM, Sohn JH, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000–2009: multicenter study. Cancer Res Treat. 2012;44:157–65.
10.
Zurück zum Zitat Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234–43.CrossRefPubMed Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol. 2010;45:234–43.CrossRefPubMed
11.
Zurück zum Zitat Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655–64.CrossRefPubMed Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655–64.CrossRefPubMed
12.
Zurück zum Zitat Konishi T, Watanabe T, Muto T, Kotake K, Nagawa H. Site distribution of gastrointestinal carcinoids differs between races. Gut. 2006;55:1051–2.CrossRefPubMedPubMedCentral Konishi T, Watanabe T, Muto T, Kotake K, Nagawa H. Site distribution of gastrointestinal carcinoids differs between races. Gut. 2006;55:1051–2.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Mandair D, Caplin ME. Colonic and rectal NET’s. Best Pract Res Clin Gastroenterol. 2012;26:775–89.CrossRefPubMed Mandair D, Caplin ME. Colonic and rectal NET’s. Best Pract Res Clin Gastroenterol. 2012;26:775–89.CrossRefPubMed
14.
Zurück zum Zitat Fan J, Han F, Liu H. Challenges of big data analysis. Natl Sci Rev. 2014;1:293–314. Fan J, Han F, Liu H. Challenges of big data analysis. Natl Sci Rev. 2014;1:293–314.
15.
Zurück zum Zitat Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994;3:205–7.PubMed Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994;3:205–7.PubMed
16.
Zurück zum Zitat Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ. Risk factors for small intestine cancer. Cancer Causes Control. 1993;4:163–9.CrossRefPubMed Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ. Risk factors for small intestine cancer. Cancer Causes Control. 1993;4:163–9.CrossRefPubMed
17.
Zurück zum Zitat Cross AJ, Leitzmann MF, Subar AF, Thompson FE, Hollenbeck AR, Schatzkin A. A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res. 2008;68:9274–9.CrossRefPubMedPubMedCentral Cross AJ, Leitzmann MF, Subar AF, Thompson FE, Hollenbeck AR, Schatzkin A. A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res. 2008;68:9274–9.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Feldman JM, Plonk JW, Bivens CH, Lebovitz HE. Glucose intolerance in the carcinoid syndrome. Diabetes. 1975;24:664–71.CrossRefPubMed Feldman JM, Plonk JW, Bivens CH, Lebovitz HE. Glucose intolerance in the carcinoid syndrome. Diabetes. 1975;24:664–71.CrossRefPubMed
19.
Zurück zum Zitat Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008;123:867–73.CrossRefPubMed Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008;123:867–73.CrossRefPubMed
20.
Zurück zum Zitat Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17:959–65.CrossRefPubMed Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17:959–65.CrossRefPubMed
21.
Zurück zum Zitat Kaerlev L, Teglbjaerg PS, Sabroe S, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control. 2002;13:27–34.CrossRefPubMed Kaerlev L, Teglbjaerg PS, Sabroe S, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control. 2002;13:27–34.CrossRefPubMed
22.
Zurück zum Zitat Mayoral W, Salcedo J, Al-Kawas F. Ampullary carcinoid tumor presenting as acute pancreatitis in a patient with von Recklinghausen’s disease: case report and review of the literature. Endoscopy. 2003;35:854–7.CrossRefPubMed Mayoral W, Salcedo J, Al-Kawas F. Ampullary carcinoid tumor presenting as acute pancreatitis in a patient with von Recklinghausen’s disease: case report and review of the literature. Endoscopy. 2003;35:854–7.CrossRefPubMed
23.
Zurück zum Zitat Halfdanarson TR, Bamlet WR, McWilliams RR, et al. Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study. Pancreas. 2014;43:1219–22.CrossRefPubMedPubMedCentral Halfdanarson TR, Bamlet WR, McWilliams RR, et al. Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study. Pancreas. 2014;43:1219–22.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hiripi E, Bermejo JL, Sundquist J, Hemminki K. Familial gastrointestinal carcinoid tumours and associated cancers. Ann Oncol. 2009;20:950–4.CrossRefPubMed Hiripi E, Bermejo JL, Sundquist J, Hemminki K. Familial gastrointestinal carcinoid tumours and associated cancers. Ann Oncol. 2009;20:950–4.CrossRefPubMed
25.
Zurück zum Zitat Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863–8.CrossRefPubMedPubMedCentral Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863–8.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Jung YS, Yun KE, Chang Y, et al. Risk factors associated with rectal neuroendocrine tumors: a cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2014;23:1406–13.CrossRefPubMed Jung YS, Yun KE, Chang Y, et al. Risk factors associated with rectal neuroendocrine tumors: a cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2014;23:1406–13.CrossRefPubMed
27.
Zurück zum Zitat Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997;66:1564s–71s.PubMed Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997;66:1564s–71s.PubMed
28.
Zurück zum Zitat Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44:634–47.CrossRefPubMed Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44:634–47.CrossRefPubMed
29.
Zurück zum Zitat Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836–42.PubMed Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836–42.PubMed
30.
Zurück zum Zitat Kesse E, Clavel-Chapelon F, Boutron-Ruault MC. Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3 N). Am J Epidemiol. 2006;164:1085–93.CrossRefPubMedPubMedCentral Kesse E, Clavel-Chapelon F, Boutron-Ruault MC. Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3 N). Am J Epidemiol. 2006;164:1085–93.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97:906–16.CrossRefPubMedPubMedCentral Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst. 2005;97:906–16.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998;148:4–16.CrossRefPubMed Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998;148:4–16.CrossRefPubMed
33.
Zurück zum Zitat Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98:241–56.CrossRefPubMed Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98:241–56.CrossRefPubMed
34.
Zurück zum Zitat Wells AM, Haub MD, Fluckey J, Williams DK, Chernoff R, Campbell WW. Comparisons of vegetarian and beef-containing diets on hematological indexes and iron stores during a period of resistive training in older men. J Am Diet Assoc. 2003;103:594–601.CrossRefPubMedPubMedCentral Wells AM, Haub MD, Fluckey J, Williams DK, Chernoff R, Campbell WW. Comparisons of vegetarian and beef-containing diets on hematological indexes and iron stores during a period of resistive training in older men. J Am Diet Assoc. 2003;103:594–601.CrossRefPubMedPubMedCentral
35.
36.
Zurück zum Zitat Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004;291:711–7.CrossRefPubMed Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004;291:711–7.CrossRefPubMed
37.
Zurück zum Zitat Piperno A, Trombini P, Gelosa M, et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens. 2002;20:1513–8.CrossRefPubMed Piperno A, Trombini P, Gelosa M, et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens. 2002;20:1513–8.CrossRefPubMed
38.
Zurück zum Zitat Halle M, Konig D, Berg A, Keul J, Baumstark MW. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis. 1997;128:235–40.CrossRefPubMed Halle M, Konig D, Berg A, Keul J, Baumstark MW. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis. 1997;128:235–40.CrossRefPubMed
39.
Zurück zum Zitat Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2001;25:639–45.CrossRefPubMed Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2001;25:639–45.CrossRefPubMed
40.
Zurück zum Zitat Mateo-Gallego R, Calmarza P, Jarauta E, Burillo E, Cenarro A, Civeira F. Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. Metabolism. 2010;59:154–8.CrossRefPubMed Mateo-Gallego R, Calmarza P, Jarauta E, Burillo E, Cenarro A, Civeira F. Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. Metabolism. 2010;59:154–8.CrossRefPubMed
41.
Zurück zum Zitat Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011;60:414–20.CrossRefPubMed Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011;60:414–20.CrossRefPubMed
43.
Zurück zum Zitat Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391:499–510.CrossRefPubMed Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391:499–510.CrossRefPubMed
44.
Zurück zum Zitat Berkovic MC, Jokic M, Marout J, Radosevic S, Zjacic-Rotkvic V, Kapitanovic S. IL-2 -330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). J Mol Med (Berl). 2010;88:423–9. Berkovic MC, Jokic M, Marout J, Radosevic S, Zjacic-Rotkvic V, Kapitanovic S. IL-2 -330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). J Mol Med (Berl). 2010;88:423–9.
45.
Zurück zum Zitat Garrelds IM, van Meeteren ME, Meijssen MA, Zijlstra FJ. Interleukin-2-deficient mice: effect on cytokines and inflammatory cells in chronic colonic disease. Dig Dis Sci. 2002;47:503–10. Garrelds IM, van Meeteren ME, Meijssen MA, Zijlstra FJ. Interleukin-2-deficient mice: effect on cytokines and inflammatory cells in chronic colonic disease. Dig Dis Sci. 2002;47:503–10.
46.
Zurück zum Zitat Yao JC, Hoff PM, Hoff AO, eds. Neuroendocrine tumors. New York: Humana, 2011. Yao JC, Hoff PM, Hoff AO, eds. Neuroendocrine tumors. New York: Humana, 2011.
47.
Zurück zum Zitat Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res. 1997;57:2238–43.PubMed Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res. 1997;57:2238–43.PubMed
48.
Zurück zum Zitat Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel–Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel-Lindau. Gastroenterology. 2000;119:1087–95. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel–Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel-Lindau. Gastroenterology. 2000;119:1087–95.
49.
Zurück zum Zitat Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel–Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153:223–31. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel–Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153:223–31.
50.
Zurück zum Zitat Cappelli C, Agosti B, Braga M, et al. Von Recklinghausen’s neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol. 2004;29:19–24.PubMed Cappelli C, Agosti B, Braga M, et al. Von Recklinghausen’s neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literature. Minerva Endocrinol. 2004;29:19–24.PubMed
51.
Zurück zum Zitat Yao JC. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab. 2007;21:163–72.CrossRefPubMed Yao JC. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab. 2007;21:163–72.CrossRefPubMed
52.
Zurück zum Zitat Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr. 1999;158:284–7.CrossRefPubMed Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr. 1999;158:284–7.CrossRefPubMed
53.
Zurück zum Zitat Eledrisi MS, Stuart CA, Alshanti M. Insulinoma in a patient with tuberous sclerosis: is there an association? Endocr Pract. 2002;8:109–12.CrossRefPubMed Eledrisi MS, Stuart CA, Alshanti M. Insulinoma in a patient with tuberous sclerosis: is there an association? Endocr Pract. 2002;8:109–12.CrossRefPubMed
54.
Zurück zum Zitat Katdare MV, Fichera A, Heimann TM. Familial rectal carcinoid: report of two first-degree relatives with rectal carcinoid and review of the literature. Tech Coloproctol. 2006;10:143–6.CrossRefPubMed Katdare MV, Fichera A, Heimann TM. Familial rectal carcinoid: report of two first-degree relatives with rectal carcinoid and review of the literature. Tech Coloproctol. 2006;10:143–6.CrossRefPubMed
55.
Zurück zum Zitat Holland PW, Rubin DB. Causal inference in retrospective studies. Eval Rev. 1988;12:203–31.CrossRef Holland PW, Rubin DB. Causal inference in retrospective studies. Eval Rev. 1988;12:203–31.CrossRef
Metadaten
Titel
Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center
verfasst von
Jeung Hui Pyo
Sung Noh Hong
Byung-Hoon Min
Jun Haeng Lee
Dong Kyung Chang
Poong-Lyul Rhee
Jae Jun Kim
Sun Kyu Choi
Sin-Ho Jung
Hee Jung Son
Young-Ho Kim
Publikationsdatum
30.03.2016
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 12/2016
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1198-9

Weitere Artikel der Ausgabe 12/2016

Journal of Gastroenterology 12/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.